We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
926
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$9.12M 0.02%
+20,200
New +$8.99M
EGHT icon
927
8x8 Inc
EGHT
$262M
$9.11M 0.02%
723,936
+499,295
+222% +$6.92M
WARR
928
DELISTED
Warrior Technologies Acquisition Company
WARR
$9.08M 0.02%
918,280
IPVI
929
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
$9.07M 0.02%
929,666
+3,591
+0.4% +$34.9K
TASK icon
930
TaskUs
TASK
$531M
$9.06M 0.02%
235,564
-412,920
-64% -$14.5M
VG
931
DELISTED
Vonage Holdings Corporation
VG
$9.05M 0.02%
445,839
+441,103
+9,314% +$9.03M
AFTR
932
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
$9.04M 0.02%
934,473
BIOT
933
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$9.03M 0.02%
916,942
CNM icon
934
Core & Main
CNM
$8.17B
$8.98M 0.02%
371,271
+155,310
+72% +$3.65M
DVA icon
935
DaVita
DVA
$15.2B
$8.98M 0.02%
+79,406
New +$8.92M
PHYT
936
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$8.95M 0.02%
900,400
PNTM.WS
937
CALL
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$8.95M 0.02%
912,213
GCTS
938
GCT Semiconductor Holding
GCTS
$180M
$8.94M 0.02%
898,900
+146,200
+19% +$1.45M
AVAC
939
DELISTED
Avalon Acquisition Inc. Class A Common Stock
AVAC
$8.93M 0.02%
896,363
CANO
940
DELISTED
Cano Health, Inc.
CANO
$8.89M 0.02%
14,006
+7,364
+111% +$4.64M
ARTE
941
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
$8.89M 0.02%
890,799
BPAC
942
DELISTED
Bullpen Parlay Acquisition Company Class A Ordinary Share
BPAC
$8.88M 0.02%
+900,000
New +$8.88M
GT icon
943
Goodyear
GT
$2.04B
$8.87M 0.02%
+620,923
New +$11M
DECK icon
944
Deckers Outdoor
DECK
$13.6B
$8.87M 0.02%
194,370
+165,888
+582% +$8.23M
PORT
945
DELISTED
Southport Acquisition Corporation
PORT
$8.85M 0.02%
+891,334
New +$8.8M
SBSW icon
946
Sibanye-Stillwater
SBSW
$6.05B
$8.84M 0.02%
544,869
+134,426
+33% +$2.18M
RCHG
947
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$8.84M 0.02%
886,420
IACC
948
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
$8.84M 0.02%
907,099
IPSC icon
949
Century Therapeutics
IPSC
$377M
$8.83M 0.02%
701,338
GWRE icon
950
Guidewire Software
GWRE
$12.4B
$8.83M 0.02%
+93,318
New +$8.92M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.